帕博利珠单抗用于治疗经一线治疗失败的不可切除或转移性黑色素瘤的预算影响分析
邵荣杰, 唐文熙, 徐赫, 金敏, 马爱霞
The Budget Impact Analysis on Introducing Pembrolizumab into Medical Insurance in Patients with Unresectable or Metastatic Melanoma after First-Line Treatment
SHAO Rong-jie, TANG Wen-xi, XU He, JIN Min, MA Ai-xia
中国药物评价
.
2020, (2): 148
-152
.
